ABSTRACT
In spite of advances in Total Joint Replacements (TJR), infection remains a major concern and a primary causative factor for revision surgery. Current clinical standards treat these osteomyelitis infections with antibiotic-laden poly(methyl methacrylate) (PMMA)-based cement, which has several disadvantages, including inadequate local drug release kinetics, antibiotic leaching for a prolonged period and additional surgical interventions to remove it, etc. Moreover, not all antibiotics (e.g., rifampicin, a potent antibiofilm antibiotic) are compatible with PMMA. For this reason, treatment of TJR-associated infections and related complications remains a significant concern. The objective of this study was to develop a polymer-controlled dual antibiotic-releasing bone void filler (ABVF) with an underlying osseointegrating substrate to treat TJR implant-associated biofilm infections. An ABVF putty was designed to provide sustained vancomycin and rifampicin antibiotic release for 6 weeks while concurrently providing an osseointegrating support for regrowth of lost bone. The reported ABVF showed efficient antibacterial and antibiofilm activity both in vitro and in a rat infection model where the ABVF both showed complete bacterial elimination and supported bone growth. Furthermore, in an in vivo k-wire-based biofilm infection model, the ABVF putty was also able to eliminate the biofilm infection while supporting osseointegration. The retrieved k-wire implants were also free from biofilm and bacterial burden. The ABVF putty delivering combination antibiotics demonstrated that it can be a viable treatment option for implant-related osteomyelitis and may lead to retention of the hardware while enabling single-stage surgery.
ABSTRACT
A (19)F DOSY protocol for the determination of formula weights for acid-base complexes in solution has been developed. (19)F internal standards were chosen and were used to evaluate the formula weights of complexes in solution using simple diffusion coefficient (D)-formula weight (FW) analysis. This method has potential applications in characterization of reactive intermediates in catalytic asymmetric reactions.
ABSTRACT
The lithium enolate of tert-amylacetate solvated by N,N,N',N'-tetramethylethylenediamine (TMEDA) is shown to be a doubly chelated dimer. Adding the dimeric enolate to 4-fluorobenzaldehyde-N-phenylimine affords an N-lithiated ß-amino ester shown to be monomeric using (6)Li and (15)N NMR spectroscopies. Rate studies using (19)F NMR spectroscopy reveal reaction orders consistent with a transition structure of stoichiometry [(ROLi)2(TMEDA)2(imine)](). Density functional theory computations explore several possible dimer-based transition structures with monodentate and bidentate coordination of TMEDA. Supporting rate studies using trans-N,N,N',N'-1,2-tetramethylcyclohexanediamine showing analogous rates and rate law suggest that TMEDA is fully chelated.
Subject(s)
Aldehydes/chemical synthesis , Aza Compounds/chemical synthesis , Ethylenediamines/chemistry , Imines/chemistry , Lithium/chemistry , Organometallic Compounds/chemistry , Aldehydes/chemistry , Aza Compounds/chemistry , Dimerization , Molecular Structure , Organometallic Compounds/chemical synthesis , SolubilityABSTRACT
A rapid and facile synthesis of cubic MCM-48 mesoporous material based on the modification of Stöber synthesis in as little time as 30 minutes at room temperature is reported in this communication.
